Mr. Corey Watton's most recent trade in Zevra Therapeutics Inc was a trade of 12,300 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | 10 Aug 2026 | 12,300 | 46,500 | - | - | Stock Option (right to buy) | ||
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.97 per share. | 10 Aug 2026 | 12,300 | 14,100 (0%) | 0% | 5.0 | 61,131 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Sale of securities on an exchange or to another person at price $ 11.25 per share. | 10 Aug 2026 | 12,300 | 1,800 (0%) | 0% | 11.3 | 138,377 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | 04 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | ||
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | ||
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 7.84 per share. | 28 Mar 2025 | 300 | 1,800 (0%) | 0% | 7.8 | 2,352 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 7.92 per share. | 11 Oct 2024 | 500 | 1,500 (0%) | 0% | 7.9 | 3,958 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | 13 May 2024 | 39,200 | 39,200 | - | - | Stock Option (right to buy) | ||
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 5.95 per share. | 23 Jun 2023 | 275 | 1,000 (0%) | 0% | 5.9 | 1,636 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 5.52 per share. | 09 Jun 2023 | 325 | 725 (0%) | 0% | 5.5 | 1,794 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 30 May 2023 | 400 | 400 (0%) | 0% | 5.1 | 2,042 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | 03 May 2023 | 58,800 | 58,800 | - | - | Stock Option (right to buy) |